Evidence map›Paper›PMID 39382960›Full record

ArticleJournal of medical Internet research2024

Development and Validation of a Computed Tomography-Based Model for Noninvasive Prediction of the T Stage in Gastric Cancer: Multicenter Retrospective Study.

Jin Tao, Dan Liu, Fu-Bi Hu, Xiao Zhang, Hongkun Yin, Huiling Zhang, Kai Zhang, Zixing Huang, Kun Yang

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Journal of medical Internet research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jin Tao *Department of General Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-1925-3601
Dan Liu *Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-6118-8997
Fu-Bi HuDepartment of Radiology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.ORCID 0000-0003-1637-2493
Xiao ZhangDepartment of Radiology, People's Hospital of Leshan, Leshan, China.ORCID 0009-0001-5005-9890
Hongkun YinInstitute of Advanced Research, Infervision Medical Technology Co Ltd, Beijing, China.ORCID 0000-0002-8595-4270
Huiling ZhangInstitute of Advanced Research, Infervision Medical Technology Co Ltd, Beijing, China.ORCID 0000-0002-8411-4253
Kai ZhangInstitute of Advanced Research, Infervision Medical Technology Co Ltd, Beijing, China.ORCID 0000-0001-9054-288X
Zixing Huang *Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0001-7967-5948
Kun Yang *Department of General Surgery and Laboratory of Gastric Cancer, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-8891-5736

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs part of the TNM (tumor-node-metastasis) staging system, T staging based on tumor depth is crucial for developing treatment plans. Previous studies have constructed a deep learning model based on computed tomographic (CT) radiomic signatures to predict the number of lymph node metastases and survival in patients with resected gastric cancer (GC). However, few studies have reported the combination of deep learning and radiomics in predicting T staging in GC.

objectiveThis study aimed to develop a CT-based model for automatic prediction of the T stage of GC via radiomics and deep learning.

methodsA total of 771 GC patients from 3 centers were retrospectively enrolled and divided into training, validation, and testing cohorts. Patients with GC were classified into mild (stage T1 and T2), moderate (stage T3), and severe (stage T4) groups. Three predictive models based on the labeled CT images were constructed using the radiomics features (radiomics model), deep features (deep learning model), and a combination of both (hybrid model).

resultsThe overall classification accuracy of the radiomics model was 64.3% in the internal testing data set. The deep learning model and hybrid model showed better performance than the radiomics model, with overall classification accuracies of 75.7% (P=.04) and 81.4% (P=.001), respectively. On the subtasks of binary classification of tumor severity, the areas under the curve of the radiomics, deep learning, and hybrid models were 0.875, 0.866, and 0.886 in the internal testing data set and 0.820, 0.818, and 0.972 in the external testing data set, respectively, for differentiating mild (stage T1~T2) from nonmild (stage T3~T4) patients, and were 0.815, 0.892, and 0.894 in the internal testing data set and 0.685, 0.808, and 0.897 in the external testing data set, respectively, for differentiating nonsevere (stage T1~T3) from severe (stage T4) patients.

conclusionsThe hybrid model integrating radiomics features and deep features showed favorable performance in diagnosing the pathological stage of GC.

Indexed as

Neoplasm StagingStomach NeoplasmsTomography, X-Ray ComputedAdultAgedDeep LearningFemaleHumansMaleMiddle AgedRetrospective Studiesaccuracybinary classificationcancercomputed tomographydeep learninggastric cancerhybrid modelmulticenter studypathological stageperformanceradiomicsT stagetumor

Identifiers

PMID39382960
PMCPMC11499715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.